SCHEMBL6563002

SCHEMBL6563002

CC1CCCN1C(=O)c1ccc(C#CCNc2ccc(C(=N)NC(=O)OC(C)(C)C)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 7/20 0.42
GAA P10253 2/20 0.42
HPGD P15428 1/20 0.42
PTPN11 Q06124 1/20 0.41
NAMPT P43490 2/20 0.40
ALDH1A1 P00352 1/20 0.40
NPC1 O15118 1/20 0.36
HSD11B1 P28845 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36
LMNA P02545 1/20 0.35
GRM5 P41594 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6565417 0.91 PTPN11 (0.36) HRH3GAAHPGDPTPN11NAMPT
SCHEMBL6563511 0.90 PTPN11 (0.40) PTPN11NPC1HSD11B1
SCHEMBL6563920 0.89 KLK5 (0.41) PTPN11ALDH1A1NPC1
SCHEMBL6561835 0.88 PTPN11 (0.35) HRH3GAAHPGDPTPN11NAMPT
SCHEMBL6563605 0.88 GAA (0.37) HRH3GAAHPGDNAMPTALDH1A1
SCHEMBL6563591 0.86 LRRK2 (0.39) HRH3GAAHPGDNAMPTALDH1A1
SCHEMBL6561858 0.86 GRM5 (0.47) HRH3HPGDPTPN11NAMPTALDH1A1
SCHEMBL7686729 0.86 PTPN11 (0.43) HPGDPTPN11NAMPTALDH1A1LMNA
SCHEMBL7674981 0.86 ABL1 (0.43) GAAHPGDPTPN11NAMPTALDH1A1
SCHEMBL6563752 0.85 GAA (0.35) HRH3GAAHPGDNAMPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140802-B1 SUBSTITUTED ARYL AND HETEROARYL DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINES BOEHRINGER INGELHEIM PHARMA (DE) 2004-03-17 EP disclosed
US-6479524-B1 TO PROLONG THE THROMBIN TIME BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-11-12 US disclosed